デフォルト表紙
市場調査レポート
商品コード
1019672

生検ガイダンスシステムの市場動向・市場シェア・市場規模の予測 (2021-2028年):製品 (定位ガイド下生検・超音波ガイド下生検・MRIガイド下生検)・用途・エンドユーザー (病院・専門クリニック)・地域別

Biopsy Guidance System Market Size, Share & Trends Analysis Report By Product (Stereotactic Guided Biopsy, MRI Guided Biopsy), By Application, By End-use (Hospitals, Specialty Clinics), By Region, And Segment Forecasts, 2021 - 2028

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 90 Pages | 納期: 2-10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
生検ガイダンスシステムの市場動向・市場シェア・市場規模の予測 (2021-2028年):製品 (定位ガイド下生検・超音波ガイド下生検・MRIガイド下生検)・用途・エンドユーザー (病院・専門クリニック)・地域別
出版日: 2021年07月08日
発行: Grand View Research, Inc.
ページ情報: 英文 90 Pages
納期: 2-10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の生検ガイダンスシステムの市場規模は予測期間中5.2%のCAGRで推移し、2028年には13億8350万米ドルの規模に成長すると予測されています。

癌の罹患率の増加、高齢者人口の増加、非侵襲的処置に対する需要の高まり、技術革新、政府の取り組みの増加、新型コロナウイルス感染症 (COVID-19) の影響などの要因が同市場の成長を推進しています。

当レポートでは、世界の生検ガイダンスシステムの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、法規制環境、市場規模の推移・予測、製品・用途・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 調査手法

第2章 調査目的

第3章 エグゼクティブサマリー

第4章 市場可変因子・動向・展望

  • 市場の見通し
  • 普及・成長の見通しマッピング
  • 規制の枠組み
  • 市場力学
  • 市場分析ツール

第5章 市場分析・予測:製品別

  • 定位ガイド下生検
  • 超音波ガイド下生検
  • MRIガイド下生検

第6章 市場分析・予測:用途別

  • 脳生検
  • 乳房生検
  • その他

第7章 市場分析・予測:エンドユーザー別

  • 病院
  • 専門クリニック
  • 診断センター
  • 研究・学術機関

第8章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合分析

  • 企業プロファイル
    • Becton, Dickinson and Company
    • Hologic, Inc.
    • Devicor Medical Products, Inc.
    • B. Braun Melsungen AG
    • ARGON MEDICAL
    • Boston Scientific Corporation
    • INRAD Inc.
    • Cook Medical
    • PLANMED OY
図表

List of Tables

  • Table 1. Global biopsy guidance systems market, by region, 2016 - 2028 (USD Million)
  • Table 2. Global biopsy guidance systems market, by product, 2016 - 2028 (USD Million)
  • Table 3. Global biopsy guidance systems market, by application, 2016 - 2028 (USD Million)
  • Table 4. Global biopsy guidance systems market, by end use, 2016 - 2028 (USD Million)
  • Table 5. North America biopsy guidance systems market, by country, 2016 - 2028 (USD Million)
  • Table 6. North America biopsy guidance systems market, by product, 2016 - 2028 (USD Million)
  • Table 7. North America biopsy guidance systems market, by application, 2016 - 2028 (USD Million)
  • Table 8. North America biopsy guidance systems market, by end use, 2016 - 2028 (USD Million)
  • Table 9. U.S. biopsy guidance systems market, by product, 2016 - 2028 (USD Million)
  • Table 10. U.S. biopsy guidance systems market, by application, 2016 - 2028 (USD Million)
  • Table 11. U.S. biopsy guidance systems market, by end use, 2016 - 2028 (USD Million)
  • Table 12. Canada biopsy guidance systems market, by product, 2016 - 2028 (USD Million)
  • Table 13. Canada biopsy guidance systems market, by application, 2016 - 2028 (USD Million)
  • Table 14. Canada biopsy guidance systems market, by end use, 2016 - 2028 (USD Million)
  • Table 15. Europe biopsy guidance systems market, by country, 2016 - 2028 (USD Million)
  • Table 16. Europe biopsy guidance systems market, by product, 2016 - 2028 (USD Million)
  • Table 17. Europe biopsy guidance systems market, by application, 2016 - 2028 (USD Million)
  • Table 18. Europe biopsy guidance systems market, by end use, 2016 - 2028 (USD Million)
  • Table 19. U.K. biopsy guidance systems market, by product, 2016 - 2028 (USD Million)
  • Table 20. U.K. biopsy guidance systems market, by application, 2016 - 2028 (USD Million)
  • Table 21. U.K. biopsy guidance systems market, by end use, 2016 - 2028 (USD Million)
  • Table 22. Germany biopsy guidance systems market, by product, 2016 - 2028 (USD Million)
  • Table 23. Germany biopsy guidance systems market, by application, 2016 - 2028 (USD Million)
  • Table 24. Germany biopsy guidance systems market, by end use, 2016 - 2028 (USD Million)
  • Table 25. Asia Pacific biopsy guidance systems market, by country, 2016 - 2028 (USD Million)
  • Table 26. Asia Pacific biopsy guidance systems market, by application, 2016 - 2028 (USD Million)
  • Table 27. Asia Pacific biopsy guidance systems market, by product, 2016 - 2028 (USD Million)
  • Table 28. Asia Pacific biopsy guidance systems market, by end use, 2016 - 2028 (USD Million)
  • Table 29. China biopsy guidance systems market, by product, 2016 - 2028 (USD Million)
  • Table 30. China biopsy guidance systems market, by application, 2016 - 2028 (USD Million)
  • Table 31. China biopsy guidance systems market, by end use, 2016 - 2028 (USD Million)
  • Table 32. Japan biopsy guidance systems market, by product, 2016 - 2028 (USD Million)
  • Table 33. Japan biopsy guidance systems market, by application, 2016 - 2028 (USD Million)
  • Table 34. Japan biopsy guidance systems market, by end use, 2016 - 2028 (USD Million)
  • Table 35. Latin America biopsy guidance systems market, by country, 2016 - 2028 (USD Million)
  • Table 36. Latin America biopsy guidance systems market, by product, 2016 - 2028 (USD Million)
  • Table 37. Latin America biopsy guidance systems market, by application, 2016 - 2028 (USD Million)
  • Table 38. Latin America biopsy guidance systems market, by end use, 2016 - 2028 (USD Million)
  • Table 39. Brazil biopsy guidance systems market, by product, 2016 - 2028 (USD Million)
  • Table 40. Brazil biopsy guidance systems market, by application, 2016 - 2028 (USD Million)
  • Table 41. Brazil biopsy guidance systems market, by end use, 2016 - 2028 (USD Million)
  • Table 42. Mexico biopsy guidance systems market, by product, 2016 - 2028 (USD Million)
  • Table 43. Mexico biopsy guidance systems market, by application, 2016 - 2028 (USD Million)
  • Table 44. Mexico biopsy guidance systems market, by end use, 2016 - 2028 (USD Million)
  • Table 45. Middle East & Africa biopsy guidance systems market, by country, 2016 - 2028 (USD Million)
  • Table 46. Middle East & Africa biopsy guidance systems market, by product, 2016 - 2028 (USD Million)
  • Table 47. Middle East & Africa biopsy guidance systems market, by application, 2016 - 2028 (USD Million)
  • Table 48. Middle East & Africa biopsy guidance systems market, by end use, 2016 - 2028 (USD Million)
  • Table 49. South Africa biopsy guidance systems market, by product, 2016 - 2028 (USD Million)
  • Table 50. South Africa biopsy guidance systems market, by application, 2016 - 2028 (USD Million)
  • Table 51. South Africa biopsy guidance systems market, by end use, 2016 - 2028 (USD Million)
  • Table 52. Saudi Arabia biopsy guidance systems market, by product, 2016 - 2028 (USD Million)
  • Table 53. Saudi Arabia biopsy guidance systems market, by application, 2016 - 2028 (USD Million)
  • Table 54. Saudi Arabia biopsy guidance systems market, by end use, 2016 - 2028 (USD Million) 

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Biopsy guidance systems market segmentation
  • Fig. 9 Market summary (2020)
  • Fig. 10 Market lineage outlook
  • Fig. 11 Penetration & growth prospect mapping
  • Fig. 12 Reimbursement pathway
  • Fig. 13 Market driver relevance analysis (Current & future impact)
  • Fig. 14 Market restraint relevance analysis (Current & future impact)
  • Fig. 15 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 16 Porter's five forces analysis
  • Fig. 17 Biopsy guidance systems market: Product movement analysis
  • Fig. 18 Biopsy guidance systems market product outlook: Key takeaways
  • Fig. 19 Stereotactic Guided Biopsy market, 2016 - 2028 (USD Million)
  • Fig. 20 Ultrasound Guided Biopsy market, 2016 - 2028 (USD Million)
  • Fig. 21 MRI Guided Biopsy market, 2016 - 2028 (USD Million)
  • Fig. 22 Biopsy guidance systems market: Application movement analysis
  • Fig. 23 Biopsy guidance systems market application outlook: Key takeaways
  • Fig. 24 Brain Biopsy market, 2016 - 2028 (USD Million)
  • Fig. 25 Breast Biopsy market, 2016 - 2028 (USD Million)
  • Fig. 26 Other Applications market, 2016 - 2028 (USD Million)
  • Fig. 27 Biopsy guidance systems market: End-use movement analysis
  • Fig. 28 Biopsy guidance systems market end-use outlook: Key takeaways
  • Fig. 29 Hospitals market, 2016 - 2028 (USD Million)
  • Fig. 30 Specialty clinics market, 2016 - 2028 (USD Million)
  • Fig. 31 Diagnostic centers market, 2016 - 2028 (USD Million)
  • Fig. 32 Research and academic institutes market, 2016 - 2028 (USD Million)
  • Fig. 33 Regional Outlook, 2020 & 2028
  • Fig. 34 Regional market place: Key takeaways
  • Fig. 35 North America biopsy guidance systems market, 2016 - 2028 (USD Million)
  • Fig. 36 U.S. biopsy guidance systems market, 2016 - 2028 (USD Million)
  • Fig. 37 Canada biopsy guidance systems market, 2016 - 2028 (USD Million)
  • Fig. 38 Europe biopsy guidance systems market, 2016 - 2028 (USD Million)
  • Fig. 39 U.K. biopsy guidance systems market, 2016 - 2028 (USD Million)
  • Fig. 40 Germany biopsy guidance systems market, 2016 - 2028 (USD Million)
  • Fig. 41 Asia Pacific biopsy guidance systems market, 2016 - 2028 (USD Million)
  • Fig. 42 Japan biopsy guidance systems market, 2016 - 2028 (USD Million)
  • Fig. 43 China biopsy guidance systems market, 2016 - 2028 (USD Million)
  • Fig. 44 Latin America biopsy guidance systems market, 2016 - 2028 (USD Million)
  • Fig. 44 Brazil biopsy guidance systems market, 2016 - 2028 (USD Million)
  • Fig. 45 Mexico biopsy guidance systems market, 2016 - 2028 (USD Million)
  • Fig. 47 Middle East & Africa biopsy guidance systems market, 2016 - 2028 (USD Million)
  • Fig. 48 South Africa biopsy guidance systems market, 2016 - 2028 (USD Million)
  • Fig. 49 Saudi Arabia biopsy guidance systems market, 2016 - 2028 (USD Million)
目次
Product Code: GVR-4-68039-395-9

Biopsy Guidance System Market Growth & Trends

The global biopsy guidance system market size is expected to reach USD 1,383.5 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.2% from 2021 to 2028. The increasing prevalence of cancer, rise in the geriatric population, growing demand for non-invasive procedures, technological innovations, a rising number of government initiatives, and impact of COVID-19 are the key driving factors for the market.

A biopsy is one of the most prominent procedures for diagnosing cancer amongst other chronic diseases, and it is commonly employed in the diagnosis of breast, brain, skin, and prostate cancer. The increasing prevalence of cancer is a major factor responsible for market growth. For instance, according to Cancer.org, in 2021, around 1.9 million new cancer cases are expected to be diagnosed in the US. Since, the biopsy guidance system is one of the major requirements for the initial diagnosis of cancer, thus, rising number of cancer cases is anticipated to propel market growth over the forecast period

Furthermore, there is a rising preference for minimally invasive biopsy treatments in the market. During the forecast period, several types of technologies and products including robot-assisted biopsy guidance systems, needle-based biopsy guns, and vacuum-assisted core biopsy systems, are expected to expand rapidly. For instance, in March 2021, IZI Medical Products, LLC launched Quick-Core Auto Biopsy System for soft tissue biopsy. It is a lightweight, completely automatic biopsy device and provides reliability, quality, and accuracy. Additionally, rising awareness of breast cancer treatment and diagnosis will further boost market growth over the forecast period.

Biopsy Guidance System Market Report Highlights

In terms of product, the stereotactic guided biopsy segment held the largest revenue share in 2020 and the ultrasound-guided biopsy segment is estimated to be the fastest-growing segment over the forecast period

In terms of application, the brain biopsy segment held the largest revenue share in 2020 and the breast biopsy segment is estimated to be the fastest-growing segment during the forecast period. The rising prevalence of brain cancer is the major factor driving the demand for brain biopsies

In terms of end-use, the hospital segment held the largest revenue share in 2020. The hospital segment's dominance is majorly attributed to the higher biopsy guiding system utilization in hospitals

North America dominated the market in 2020 owing to numerous factors such as enhanced infrastructure, rising patient awareness, and the presence of key players in the region

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research Methodology
    • 1.1.1 Information procurement
  • 1.2 Information or Data Analysis
  • 1.3 Market Formulation & Validation
  • 1.4 Region Wise Market Calculation
    • 1.4.1 Region Wise Market: Base Estimates
    • 1.4.2 Global Market: CAGR Calculation
  • 1.5 Region Based Segment Share Calculation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.2 Volume price analysis (Model 2)
  • 1.7 List of Secondary Sources

Chapter 2 Objectives

  • 2.1 Objective - 1:
  • 2.2 Objective - 2:
  • 2.3 Objective - 3:
  • 2.4 Objective - 4:

Chapter 3 Executive Summary

  • 3.1 Market Outlook
  • 3.2 Segment Outlook
  • 3.3 Competitive Insights
    • 3.3.1 Market Segmentation
  • 3.4 Market Snapshot

Chapter 4 Biopsy Guidance Systems Market Variables, Trends & Scope

  • 4.1 Market Lineage Outlook
    • 4.1.1 Parent market outlook
    • 4.1.2 Ancillary Market
  • 4.2 Penetration & Growth Prospect Mapping
  • 4.3 Regulatory Framework
  • 4.4 Market Dynamics
    • 4.4.1 Market driver analysis
      • 4.4.1.1 Rising prevalence of cancer
      • 4.4.1.2 Increasing preference for non-invasive procedures
      • 4.4.1.3 Technological advancements
    • 4.4.2 Market restraint analysis
      • 4.4.2.1 Stringent manufacturing policies
      • 4.4.2.2 High cost of biopsy guidance systems
  • 4.5 Biopsy Guidance Systems Market Analysis Tools
    • 4.5.1 SWOT Analysis, by PEST
    • 4.5.2 Porter's five forces analysis

Chapter 5 Biopsy Guidance Systems Market: Segment Analysis, By Product, 2016 - 2028 (USD Million)

  • 5.1 Definitions & Scope
  • 5.2 Product Market Share Analysis, 2020 & 2028
  • 5.3 Biopsy Guidance Systems Market, by Product, 2016 to 2028
  • 5.4 Market Size Forecasts and Trend Analysis
    • 5.4.1 Stereotactic guided biopsy
      • 5.4.1.1 Stereotactic guided biopsy market, 2016 - 2028 (USD Million)
    • 5.4.2 Ultrasound guided biopsy
      • 5.4.2.1 Ultrasound guided biopsy market, 2016 - 2028 (USD Million)
    • 5.4.3 MRI guided biopsy
      • 5.4.3.1 MRI guided biopsy market, 2016 - 2028 (USD Million)

Chapter 6 Biopsy Guidance Systems Market: Segment Analysis, By Application, 2016 - 2028 (USD Million)

  • 6.1 Definitions & Scope
  • 6.2 Application Market Share Analysis, 2020 & 2028
  • 6.3 Biopsy Guidance Systems Market, by Application, 2016 to 2028
  • 6.4 Market Size Forecasts and Trend Analysis
    • 6.4.1 Brain biopsy
      • 6.4.1.1 Brain biopsy market, 2016 - 2028 (USD Million)
    • 6.4.2 Breast biopsy
      • 6.4.2.1 Breast biopsy market, 2016 - 2028 (USD Million)
    • 6.4.3 Other applications
      • 6.4.3.1 Other applications market, 2016 - 2028 (USD Million)

Chapter 7 Biopsy Guidance Systems Market: Segment Analysis, By End Use, 2016 - 2028 (USD Million)

  • 7.1 Definitions & Scope
  • 7.2 End-use Market Share Analysis, 2020 & 2028
  • 7.3 Biopsy Guidance Systems Market, By End Use, 2016 to 2028
  • 7.4 Market Size Forecasts and Trend Analysis
    • 7.4.1 Hospitals
      • 7.4.1.1 Hospitals market, 2016 - 2028 (USD Million)
    • 7.4.2 Specialty clinics
      • 7.4.2.1 Specialty clinics market, 2016 - 2028 (USD Million)
    • 7.4.3 Diagnostic centers
      • 7.4.3.1 Diagnostic centers market, 2016 - 2028 (USD Million)
    • 7.4.4 Research and academic institutes
      • 7.4.4.1 Research and academic institutes market, 2016 - 2028 (USD Million)

Chapter 8 Biopsy Guidance Systems Market: Regional Market Analysis, By Product, Application, and End-use, 2016 - 2028 (USD Million)

  • 8.1 Definitions & Scope
  • 8.2 Regional Market Share Analysis, 2020 & 2028
  • 8.3 Regional Market Snapshot
  • 8.4 Market Size Forecasts & Trend Analysis
    • 8.4.1 North America
      • 8.4.1.1 North America biopsy guidance systems market, 2016 - 2028 (USD Million)
      • 8.4.1.2 U.S.
      • 8.4.1.2.1 U.S. biopsy guidance systems market, 2016 - 2028 (USD Million)
      • 8.4.1.3 Canada
      • 8.4.1.3.1 Canada biopsy guidance systems market, 2016 - 2028 (USD Million)
    • 8.4.2 Europe
      • 8.4.2.1 Europe biopsy guidance systems market, 2016 - 2028 (USD Million)
      • 8.4.2.2 U.K.
      • 8.4.2.2.1 U.K. biopsy guidance systems market, 2016 - 2028 (USD Million)
      • 8.4.2.3 Germany
      • 8.4.2.3.1 Germany biopsy guidance systems market, 2016 - 2028 (USD Million)
    • 8.4.3 Asia Pacific
      • 8.4.3.1 Asia Pacific biopsy guidance systems market, 2016 - 2028 (USD Million)
      • 8.4.3.2 Japan
      • 8.4.3.2.1 Japan biopsy guidance systems market, 2016 - 2028 (USD Million)
      • 8.4.3.3 China
      • 8.4.3.3.1 China biopsy guidance systems market, 2016 - 2028 (USD Million)
    • 8.4.4 Latin America
      • 8.4.4.1 Latin America biopsy guidance systems market, 2016 - 2028 (USD Million)
      • 8.4.4.2 Brazil
      • 8.4.4.2.1 Brazil biopsy guidance systems market, 2016 - 2028 (USD Million)
      • 8.4.4.3 Mexico
      • 8.4.4.3.1 Mexico biopsy guidance systems market, 2016 - 2028 (USD Million)
    • 8.4.5 Middle East & Africa
      • 8.4.5.1 Middle East & Africa biopsy guidance systems market, 2016 - 2028 (USD Million)
      • 8.4.5.2 South Africa
      • 8.4.5.2.1 South Africa biopsy guidance systems market, 2016 - 2028 (USD Million)
      • 8.4.5.3 Saudi Arabia
      • 8.4.5.3.1 Saudi Arabia biopsy guidance systems market, 2016 - 2028 (USD Million)

Chapter 9 Biopsy Guidance Systems Market: Competitive Analysis

  • 9.1 Company Profiles
    • 9.1.1 Becton, Dickinson and Company
      • 9.1.1.1 Company overview
      • 9.1.1.2 Financial performance
      • 9.1.1.3 Product benchmarking
      • 9.1.1.4 Strategic initiatives
    • 9.1.2 Hologic, Inc.
      • 9.1.2.1 Company overview
      • 9.1.2.2 Financial performance
      • 9.1.2.3 Product benchmarking
      • 9.1.2.4 Strategic initiatives
    • 9.1.3 Devicor Medical Products, Inc.
      • 9.1.3.1 Company overview
      • 9.1.3.2 Financial performance
      • 9.1.3.3 Product benchmarking
      • 9.1.3.4 Strategic initiatives
    • 9.1.4 B. Braun Melsungen AG
      • 9.1.4.1 Company overview
      • 9.1.4.2 Financial performance
      • 9.1.4.3 Product benchmarking
      • 9.1.4.4 Strategic initiatives
    • 9.1.5 ARGON MEDICAL
      • 9.1.5.1 Company overview
      • 9.1.5.2 Financial performance
      • 9.1.5.3 Product benchmarking
      • 9.1.5.4 Strategic initiatives
    • 9.1.6 Boston Scientific Corporation
      • 9.1.6.1 Company overview
      • 9.1.6.2 Financial performance
      • 9.1.6.3 Product benchmarking
      • 9.1.6.4 Strategic initiatives
    • 9.1.7 INRAD Inc.
      • 9.1.7.1 Company overview
      • 9.1.7.2 Financial performance
      • 9.1.7.3 Product benchmarking
      • 9.1.7.4 Strategic initiatives
    • 9.1.8 Cook Medical
      • 9.1.8.1 Company overview
      • 9.1.8.2 Financial performance
      • 9.1.8.3 Product benchmarking
      • 9.1.8.4 Strategic initiatives
    • 9.1.9 PLANMED OY
      • 9.1.9.1 Company overview
      • 9.1.9.2 Financial performance
      • 9.1.9.3 Product benchmarking
      • 9.1.9.4 Strategic initiatives